These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15867102)

  • 21. Visual sensory processing deficits in Schizophrenia and their relationship to disease state.
    Yeap S; Kelly SP; Sehatpour P; Magno E; Garavan H; Thakore JH; Foxe JJ
    Eur Arch Psychiatry Clin Neurosci; 2008 Aug; 258(5):305-16. PubMed ID: 18504634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anomalous visual experiences, negative symptoms, perceptual organization and the magnocellular pathway in schizophrenia: a shared construct?
    Kéri S; Kiss I; Kelemen O; Benedek G; Janka Z
    Psychol Med; 2005 Oct; 35(10):1445-55. PubMed ID: 16164768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual sensory processing deficits in schizophrenia: is there anything to the magnocellular account?
    Lalor EC; De Sanctis P; Krakowski MI; Foxe JJ
    Schizophr Res; 2012 Aug; 139(1-3):246-52. PubMed ID: 22704644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications.
    Martínez A; Gaspar PA; Hillyard SA; Andersen SK; Lopez-Calderon J; Corcoran CM; Javitt DC
    Am J Psychiatry; 2018 Dec; 175(12):1243-1254. PubMed ID: 30278791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New results in the experimental psychopathology of visual dysfunctions in schizophrenia].
    Must A
    Psychiatr Hung; 2005; 20(3):201-10. PubMed ID: 16395954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-stage visual processing deficits in schizophrenia.
    Butler PD; Javitt DC
    Curr Opin Psychiatry; 2005 Mar; 18(2):151-7. PubMed ID: 16639168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady state responses: electrophysiological assessment of sensory function in schizophrenia.
    Brenner CA; Krishnan GP; Vohs JL; Ahn WY; Hetrick WP; Morzorati SL; O'Donnell BF
    Schizophr Bull; 2009 Nov; 35(6):1065-77. PubMed ID: 19726534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: implications for pathophysiology of executive dysfunction in schizophrenia.
    Wylie GR; Clark EA; Butler PD; Javitt DC
    Schizophr Bull; 2010 May; 36(3):585-94. PubMed ID: 18835838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired P100 among regular cannabis users in response to magnocellular biased visual stimuli.
    Remy I; Schwitzer T; Albuisson É; Schwan R; Krieg J; Bernardin F; Ligier F; Lalanne L; Maillard L; Laprevote V
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110437. PubMed ID: 34520807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Backward masking in unmedicated schizophrenic patients in psychotic remission: possible reflection of aberrant cortical oscillation.
    Green MF; Nuechterlein KH; Breitmeyer B; Mintz J
    Am J Psychiatry; 1999 Sep; 156(9):1367-73. PubMed ID: 10484946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual information processing deficits as biomarkers of vulnerability to schizophrenia: an event-related potential study in schizotypy.
    Koychev I; El-Deredy W; Haenschel C; Deakin JF
    Neuropsychologia; 2010 Jun; 48(7):2205-14. PubMed ID: 20412812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual mismatch negativity among patients with schizophrenia.
    Urban A; Kremlácek J; Masopust J; Libiger J
    Schizophr Res; 2008 Jul; 102(1-3):320-8. PubMed ID: 18472402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging.
    Martínez A; Hillyard SA; Dias EC; Hagler DJ; Butler PD; Guilfoyle DN; Jalbrzikowski M; Silipo G; Javitt DC
    J Neurosci; 2008 Jul; 28(30):7492-500. PubMed ID: 18650327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On identifying magnocellular and parvocellular responses on the basis of contrast-response functions.
    Skottun BC; Skoyles JR
    Schizophr Bull; 2011 Jan; 37(1):23-6. PubMed ID: 20929967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnocellular visual evoked potential delay with high autism spectrum quotient yields a neural mechanism for altered perception.
    Sutherland A; Crewther DP
    Brain; 2010 Jul; 133(Pt 7):2089-97. PubMed ID: 20513659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early visual processing deficits in dysbindin-associated schizophrenia.
    Donohoe G; Morris DW; De Sanctis P; Magno E; Montesi JL; Garavan HP; Robertson IH; Javitt DC; Gill M; Corvin AP; Foxe JJ
    Biol Psychiatry; 2008 Mar; 63(5):484-9. PubMed ID: 17945199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of Early-Stage Visual Processing Deficits at Schizophrenia Spectrum Illness Onset Using Magnetoencephalography.
    Sklar AL; Coffman BA; Salisbury DF
    Schizophr Bull; 2020 Jul; 46(4):955-963. PubMed ID: 32052843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast sensitivity and magnocellular functioning in schizophrenia.
    Skottun BC; Skoyles JR
    Vision Res; 2007 Oct; 47(23):2923-33. PubMed ID: 17825350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
    Light GA; Braff DL
    Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Objective Assessment of the Effect of Optical Treatment on Magnocellular and Parvocellular-biased Visual Response in Anisometropic Amblyopia.
    Liu Z; Chen Z; Xu Y; Feng L; Yuan J; Deng D; Han Y; Yu M
    Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):21. PubMed ID: 32058564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.